PLAU and prostate carcinoma: In fact, a study using prostate cancer cells reported that SERPINE2 promoted apoptosis [9], whereas a study by Xu et al. [37] showed that SERPINE2-induced inhibition of urokinase-type plasminogen activator prevented prostate cancer cell invasion.